CXCL8 and polycystic ovary syndrome: The molecular docking results showed that the biologically active components in C. chinensis inhibit cell inflammation by regulating the expression of MAPK1, IL-6, CXCL8, and IL1B, thereby exerting a therapeutic effect on PCOS.